双鹭药业：10月24日召开董事会会议

Company Overview - Shuanglu Pharmaceutical (SZ 002038) announced the convening of its 8th meeting of the 9th Board of Directors on October 24, 2025, to review the proposal for the Q3 2025 report [1] - As of the report date, Shuanglu Pharmaceutical has a market capitalization of 7.7 billion yuan [1] Revenue Composition - For the first half of 2025, the revenue composition of Shuanglu Pharmaceutical is as follows: 97.48% from the pharmaceutical industry and 2.52% from other businesses [1]